Corneal cross linking

Helping patients with keratoconus

Collagen cross linking (CXL) is the only currently available treatment that prevents the progression of keratoconus. Success rates have been measured in clinical trials at 90%. You can access Rapid CXL treatment with the assistance of Mr Alfonso and the team at Moorfields Eye Hospital in London.




a person experiencing keratoconus in their right eye

Why is CXL necessary?

Keratoconus is caused by the weakening of the cornea, and where this is confirmed continuous progression on corneal thinning and deformation, corneal cross-linking is recommended.

It is especially beneficial for younger patients under 35, as keratoconus usually stops getting worse by age 35. CXL uses ultraviolet light and vitamin B2 drops to stiffen the cornea.

This causes fibres within the cornea to cross-link, and mimics the age-related stiffening of the cornea. 




Book an appointment for keratoconus today

If you believe you may need a consultation for corneal cross linking, arrange with Mr Alfonso Vasquez-Perez today.

Arrange a Consultation






What are the risks?

There is a small risk that the treatment can make eyesight worse, although this is outweighed by the likelihood of eyesight becoming worse if the condition is untreated. You will need to allow at least one week off work and use eye-drops frequently in the following days to help the eye heal properly. Mr Alfonso Vasquez-Perez will discuss with you about the best way to proceed, so you can make the most informed choice. 

a person with corneal cross linking in her eye